Investigating association between inflammatory bowel disease and rotavirus vaccination in a paediatric cohort in the

Aidan Flatt1,2, Thomas Inns2, Kate M Fleming1

  • 1Institute of Population Health, Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.

PubMed

Insights

This study found no significant link between infant rotavirus vaccination and the development of inflammatory bowel disease (IBD) in children. The research provides further evidence supporting the safety of rotavirus vaccines.

Area of Science:

  • Pediatric Gastroenterology
  • Vaccinology
  • Epidemiology

Background:

  • Inflammatory bowel disease (IBD) incidence is rising in UK pediatric populations.
  • Environmental factors, such as acute gastroenteritis (AGE), may influence IBD development.
  • Infant rotavirus vaccination reduces AGE, prompting investigation into its potential impact on IBD.

Purpose of the Study:

  • To investigate the association between live oral rotavirus vaccination and the subsequent development of IBD in children.
  • To assess the safety profile of rotavirus vaccines concerning IBD risk.

Main Methods:

  • Population-based cohort study utilizing UK primary care data (Clinical Practice Research Datalink Aurum).
  • Analysis of children born between 2010-2015, followed from 6 months to 7 years.
  • Cox regression analysis adjusted for confounding factors to determine the hazard ratio for IBD following rotavirus vaccination.

Main Results:

  • A cohort of 907,477 children was analyzed, with 96 cases of IBD.
  • The adjusted hazard ratio for rotavirus vaccination and IBD was 1.19 (95% CI 0.53-2.69), indicating no statistically significant association.
  • The study found no statistically significant association between rotavirus vaccination and IBD development.

Conclusions:

  • Live oral rotavirus vaccination is not significantly associated with an increased risk of developing IBD in children.
  • The findings contribute to the body of evidence supporting the safety of rotavirus vaccination programs.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
364
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
Vaccinations01:51

Vaccinations

Overview
44.8K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
174
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
159